New insights into the role of vascular adhesion molecules in cardiovascular diseases

Editorial Checklist Reviewed
Compuscript LtdAug 19 2024NewsGuard 100/100 Score

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Vascular Adhesion Molecules (VAMs) appear to play important roles in the development of Cardiovascular Diseases (CVD).

The roles of these molecules in mediating inflammation, endothelial dysfunction, and plaque formation suggest that they may be important as both biomarkers and therapeutic targets. Understanding and targeting these molecules are hoped to substantially contribute to improving the prevention and biomarker-guided treatment of CVD.

Source:

Compuscript Ltd

Journal reference:

Berezin, A. E. (2024). The Plausible Role of Vascular Adhesion Molecules in Cardiovascular Diseases. Cardiovascular Innovations and Applications. doi.org/10.15212/cvia.2024.0046.

Posted in: Medical Science News | Medical Research News | Medical Condition News

Tags: , ,

Comments (0)

Suggested Reading

Anti-inflammatory cytokine linked to capillary obstruction and cognitive decline in diabetes
Scientists unveil a 3D photoacoustic scanner that speeds up vascular imaging for real-time clinical use
Migraines linked to healthy vascular system despite cardiovascular risk factors
AI model analyzes retinal images to detect early Alzheimer’s disease and cognitive decline
The long-term cardiac impact of COVID-19
Spermidine regulates RIPK1 to combat diabetes and vascular damage
Stress, diet, and vascular health: Can cocoa flavonols help?
Key kinase involved in cell division linked to abnormal blood vessel growth in genetic disorder

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation